The House Committee on Small Business wrote to Commissioner Robert Califf of the U.S. Food and Drug Administration (FDA) regarding their policy of not discussing proposed rules with Congress. The Committee vehemently disagrees with the FDA's policy.

November 20, 2023.

Read the full letter here.